The Group's principal activities are to discover, develop, manufacture and market novel health care solutions. The Group operates through two Divisions, namely Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of Roche Pharmaceuticals along with Genentech and Chugai which the company has majority shareholdings in. It focuses on innovative medicines primarily in the areas of Oncology, Autoimmunity, Metabolism, Virology and CNS. The Diagnostics Division provides products and services for in-vitro diagnostic testing, which includes reagents and instrumentation in the area of molecular biology, clinical chemistry, immunochemistry, hematology and coagulation. The Diagnostics division consists of five business areas: Diabetes Care, Professional Diagnostics, Molecular Diagnostics, Tissue Diagnostics and Applied Science. It operates in over 180 countries worldwide.
Alacra Alerts:
Receive alerts on the latest reports on Roche Holding Ltd.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
